• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Arch Gynecol Obstet . Comparison of clinical features and perinatal outcomes between pre-variant and post-variant periods in pregnant women with SA

tetano

Editor, Senior Moderator
Arch Gynecol Obstet


. 2022 Mar 7.
doi: 10.1007/s00404-022-06493-5. Online ahead of print.
Comparison of clinical features and perinatal outcomes between pre-variant and post-variant periods in pregnant women with SARS-CoV-2: analysis of 1935 cases


Dilek Sahin[SUP] 1 [/SUP], Atakan Tanacan[SUP] 2 [/SUP], Ali Taner Anuk[SUP] 3 [/SUP], Selcan Sinaci[SUP] 3 [/SUP], Berhan Besimoglu[SUP] 3 [/SUP], Deniz Oluklu[SUP] 3 [/SUP], Derya Uyan Hendem[SUP] 3 [/SUP], Dilek Menekse Beser[SUP] 3 [/SUP], Muradiye Yildirim[SUP] 3 [/SUP], Bedri Sakcak[SUP] 3 [/SUP], Seyit Ahmet Erol[SUP] 3 [/SUP], Yeliz Colakoglu[SUP] 3 [/SUP], Sule Goncu Ayhan[SUP] 3 [/SUP], Ezgi Turgut[SUP] 3 [/SUP], Serpil Unlu[SUP] 4 [/SUP], Fuat Emre Canpolat[SUP] 5 [/SUP], Seval Izdes[SUP] 6 [/SUP], Sema Turan[SUP] 7 [/SUP], Aziz Ahmet Surel[SUP] 8 [/SUP], Ozlem Moraloglu Tekin[SUP] 1 [/SUP]



Affiliations

Abstract

Purpose: To compare the clinical features and perinatal outcomes of pregnant women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the pre-variant and post-variant periods.
Methods: This prospective cohort study includes pregnant women with SARS-CoV-2 who were followed-up at Ankara City Hospital between 11, March 2020 and 15, September 2021. Demographic features, clinical characteristics and pregnancy outcomes were compared between the pre-variant (n = 1416) and post-variant (n = 519) groups.
Results: The rates of severe and critical cases significantly increased in the post-variant group (9.7% vs 2%, p < 0.001). The rates of respiratory support (26.8% vs 7.3%, p < 0.001), ICU admission (12.9% vs 1.8%, p < 0.001) and maternal mortality (2.9% vs 0.4%, p < 0.001) were significantly higher in the post-variant group. A significant increase was observed for pregnancy complications in the post-variant group (45.6% vs 18.8%, p = 0.007). The rates of preterm delivery (26.4% vs 4.4%, p < 0.001) and NICU admission (34% vs 18.8%, p < 0.001) were significantly higher in the post-variant group. Positive, weak, statistically significant correlations were observed between the post-variant period, disease severity and maternal mortality (r = 0.19, r = 0.12 and p < 0.001).
Conclusion: Post-variant COVID-19 period was associated with a severe course of the disease and increased rates of adverse obstetric outcomes in pregnant patients.

Keywords: COVID-19; COVID-19 variants; Disease severity; Obstetric complications; Pregnancy; SARS-CoV-2.
 
Back
Top Bottom